Genmab

GMAB · Nasdaq Copenhagen · DKK

kr 2,257.00Change from previous close: −2.42%Absolute change: −kr 56.00

Close · October 2, 2026

At a glance

Revenue growth
+19.19%
2025 vs 2024
Net income growth
−15.00%
2025 vs 2024
Net margin
25.9%
2024: 36.3%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Cash flow · Quarterly
ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Operating cash flow51.03.030153662.0287424304219219248289
Depreciation and amortization16.019.015.016.016.016.010.616.814.013.08.612.1
Capital expenditure-2.0-5.0-13.0-2.0-10.0-12.0-14.1-5.7-4.0-4.0-9.9-13.9
Investing cash flow2.0-9.0-5,572-54.026.0-43.0-60.333.5-1,270-210-65.5143
Financing cash flow-75.0-1775,229-21.0-406-13.0-21.5-41.3-440-85.0-3.32.8
Share repurchases-9.0-110-3.0-25.0-408-12.0-23.5-45.2-439-91.0-0.9-0.6
Debt issued——5,500—————————
Debt repaid-65.0-69.0-2.0-5.0-4.0-2.0-0.7-2.5-3.0-3.0-3.7-2.3
Effect of exchange rates4.0-11.0-4.04.0-5.08.017.64.5-14.0-1.0-91.147.4
Net change in cash-18.0-194-46.0465-323239359301-1,505-77.088.1482
Free cash flow49.0-2.028853452.0275410298215215238275
Levered free cash flow-67.433.6469364-104271278213200174193185